155 related articles for article (PubMed ID: 15569528)
21. [Cloning of expression vector of human tissue factor gene and its expression in human ovarian cancer cell line].
Fang J; Wei WN; Liu ZP; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):579-82. PubMed ID: 14706138
[TBL] [Abstract][Full Text] [Related]
22. Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor.
Bromberg ME; Bailly MA; Konigsberg WH
Thromb Haemost; 2001 Nov; 86(5):1210-4. PubMed ID: 11816709
[TBL] [Abstract][Full Text] [Related]
23. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
[TBL] [Abstract][Full Text] [Related]
24. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
Ott I; Weigand B; Michl R; Seitz I; Sabbari-Erfani N; Neumann FJ; Schömig A
Circulation; 2005 Jan; 111(3):349-55. PubMed ID: 15642762
[TBL] [Abstract][Full Text] [Related]
25. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
[TBL] [Abstract][Full Text] [Related]
27. [Role of tissue factor pathway inhibitor-2 in ovarian tumor migration and invasion].
Zhong R; Huang RB; Song SJ
Ai Zheng; 2003 Oct; 22(10):1038-41. PubMed ID: 14558946
[TBL] [Abstract][Full Text] [Related]
28. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
Wang J; Zhang CQ; Liu J; Sui LH
Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
30. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
Lai RX; Zhang SN; Nakamura T; Yuan SZ
Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
[TBL] [Abstract][Full Text] [Related]
31. Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells.
Müller M; Albrecht S; Gölfert F; Hofer A; Funk RH; Magdolen V; Flössel C; Luther T
Exp Cell Res; 1999 Apr; 248(1):136-47. PubMed ID: 10094821
[TBL] [Abstract][Full Text] [Related]
32. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.
Prezas P; Arlt MJ; Viktorov P; Soosaipillai A; Holzscheiter L; Schmitt M; Talieri M; Diamandis EP; Krüger A; Magdolen V
Biol Chem; 2006 Jun; 387(6):807-11. PubMed ID: 16800744
[TBL] [Abstract][Full Text] [Related]
34. [Steep pulse changes the expression of tissue factor in ovarian tumor].
Li C; Hu L; Wang P; Dong X; Zhu Y; Yao C; Mi Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):402-6. PubMed ID: 18610631
[TBL] [Abstract][Full Text] [Related]
35. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
[TBL] [Abstract][Full Text] [Related]
36. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
37. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2.
Zhang A; Meng L; Wang Q; Xi L; Chen G; Wang S; Zhou J; Lu Y; Ma D
Oncol Rep; 2006 Apr; 15(4):831-6. PubMed ID: 16525667
[TBL] [Abstract][Full Text] [Related]
38. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
Jiang X; Guo YL; Bromberg ME
Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
[TBL] [Abstract][Full Text] [Related]
39. [Antitumor effect of endothelial progenitor cells with TRAIL gene transfection on ovarian carcinoma xenografts in nude mice].
Zhou L; Yan MX; Yao M; Feng YJ
Ai Zheng; 2005 Nov; 24(11):1312-6. PubMed ID: 16552954
[TBL] [Abstract][Full Text] [Related]
40. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
